Why the study?
Heart failure is a leading cause of worldwide hospital admissions, and while treatments prevent HFrEF progression, few have proven effective for improving HFpEF survival.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
This review highlights the current understanding of heart failure pathogenesis and the potential of cardiac regenerative therapies for future clinical translation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: